NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL

PTP-001

Allogeneic human placental tissue particulate (PTP-001) is administered as a single intra-articular injection to the target knee after resuspension with saline.

OTHER

Placebo control

The placebo control, physiological saline (0.9% sodium chloride injection, USP), is administered as an intra-articular injection to the target knee.

Trial Locations (14)

2010

Holdsworth House Medical Practice, Sydney

2019

Emeritus Research Sydney, Botany

2292

Genesis Research Services, Broadmeadow

2730

Sanos Clinic, Herlev

3124

Emeritus Research Melbourne, Camberwell

7100

Sanos Clinic Syddanmark, Vejle

9362

Sanos Clinic Nordjylland, Gandrup

Unknown

Royal North Shore Hospital, Saint Leonards

L8M 1K7

Hamilton Medical Research Group, Hamilton

L8N 4A6

McMaster University Department of Surgery St. Joseph's Healthcare Hamilton, Hamilton

M3J 0K2

Canadian Phase Onward Inc., Toronto

G1N4V3

Diex Recherche Quebec Inc., Québec

G1W 4R4

Centrede Recherche Saint-Louis, Québec

J1L 0H8

Diex Recherche Sherbrooke Inc., Sherbrooke